NO20001749L - Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat - Google Patents

Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat

Info

Publication number
NO20001749L
NO20001749L NO20001749A NO20001749A NO20001749L NO 20001749 L NO20001749 L NO 20001749L NO 20001749 A NO20001749 A NO 20001749A NO 20001749 A NO20001749 A NO 20001749A NO 20001749 L NO20001749 L NO 20001749L
Authority
NO
Norway
Prior art keywords
asymmetric
preparation
cyclic urea
urea compounds
monoacylated
Prior art date
Application number
NO20001749A
Other languages
English (en)
Norwegian (no)
Other versions
NO20001749D0 (no
Inventor
Benjamin R P Stone
Luigi Anzalone
Joseph M Fortunak
Gregory David Harris
Ioannis I Valvis
Robert Eugebe Waltermire
Original Assignee
Du Pont Pharm Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Du Pont Pharm Co filed Critical Du Pont Pharm Co
Publication of NO20001749D0 publication Critical patent/NO20001749D0/no
Publication of NO20001749L publication Critical patent/NO20001749L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D491/00Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00
    • C07D491/02Heterocyclic compounds containing in the condensed ring system both one or more rings having oxygen atoms as the only ring hetero atoms and one or more rings having nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D451/00 - C07D459/00, C07D463/00, C07D477/00 or C07D489/00 in which the condensed system contains two hetero rings
    • C07D491/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • A61P31/14Antivirals for RNA viruses
    • A61P31/18Antivirals for RNA viruses for HIV
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D243/00Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
    • C07D243/04Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 3
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D317/00Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28Radicals substituted by nitrogen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • AIDS & HIV (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
NO20001749A 1997-10-06 2000-04-05 Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat NO20001749L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6119597P 1997-10-06 1997-10-06
PCT/US1998/021051 WO1999018085A2 (en) 1997-10-06 1998-10-06 Preparation of asymmetric cyclic ureas through a monoacylated diamine intermediate

Publications (2)

Publication Number Publication Date
NO20001749D0 NO20001749D0 (no) 2000-04-05
NO20001749L true NO20001749L (no) 2000-06-05

Family

ID=22034252

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20001749A NO20001749L (no) 1997-10-06 2000-04-05 Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat

Country Status (19)

Country Link
US (2) US6218534B1 (et)
EP (1) EP1025092A2 (et)
JP (1) JP2001519335A (et)
KR (1) KR20010024403A (et)
CN (1) CN1273586A (et)
AR (1) AR017763A1 (et)
AU (1) AU9788198A (et)
BR (1) BR9815400A (et)
CA (1) CA2304513A1 (et)
EE (1) EE200000157A (et)
HR (1) HRP980538A2 (et)
HU (1) HUP0003933A3 (et)
IL (1) IL135470A0 (et)
NO (1) NO20001749L (et)
PL (1) PL340238A1 (et)
SK (1) SK4732000A3 (et)
TW (1) TW505649B (et)
WO (1) WO1999018085A2 (et)
ZA (1) ZA989099B (et)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7449111B2 (en) * 2003-07-30 2008-11-11 Arkema Inc. Resins containing ionic or ionizable groups with small domain sizes and improved conductivity

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5610294A (en) 1991-10-11 1997-03-11 The Du Pont Merck Pharmaceutical Company Substituted cyclic carbonyls and derivatives thereof useful as retroviral protease inhibitors
US5530124A (en) 1994-06-30 1996-06-25 The Dupont Merck Pharmaceutical Company Method for preparing cyclic ureas and their use for the synthesis of HIV protease inhibitors
US5532356A (en) 1995-06-06 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N,N'-disubstituted cyclic ureas
US5532357A (en) 1995-06-07 1996-07-02 The Dupont Merck Pharmaceutical Company Method for preparing N-monosubstituted and N,N'-disubstituted unsymmetrical cyclic ureas
US5998614A (en) * 1997-07-07 1999-12-07 Dupont Pharmaceuticals Company Preparation of asymmetric cyclic ureas using an alkali metal in liquid ammonia process

Also Published As

Publication number Publication date
HRP980538A2 (en) 1999-10-31
EE200000157A (et) 2001-02-15
SK4732000A3 (en) 2001-03-12
US20010020093A1 (en) 2001-09-06
KR20010024403A (ko) 2001-03-26
WO1999018085A3 (en) 1999-06-24
AR017763A1 (es) 2001-10-24
JP2001519335A (ja) 2001-10-23
BR9815400A (pt) 2001-09-25
HUP0003933A3 (en) 2001-12-28
US6452000B2 (en) 2002-09-17
PL340238A1 (en) 2001-01-29
TW505649B (en) 2002-10-11
EP1025092A2 (en) 2000-08-09
ZA989099B (en) 2000-04-06
CA2304513A1 (en) 1999-04-15
CN1273586A (zh) 2000-11-15
NO20001749D0 (no) 2000-04-05
US6218534B1 (en) 2001-04-17
HUP0003933A2 (hu) 2001-10-28
WO1999018085A2 (en) 1999-04-15
AU9788198A (en) 1999-04-27
IL135470A0 (en) 2001-05-20

Similar Documents

Publication Publication Date Title
EA200300803A1 (ru) Производные ксантина, их получение и их применение в качестве лекарственных средств
TR200100238T2 (tr) Yeni sübstitüe edilmiş pirazol türevleri
YU38799A (sh) Disupstituisani biciklični heterocikli,njihovo dobijanje i njihova primena kao lekova
ID21547A (id) Kristal-kristal dari turunan benzimidazol dan produksinya
NO933248L (no) Cykliske urinstoffderivater, legemidler inneholdende disse forbindelser, og fremgangsmåte for deres fremstilling
NO20083684L (no) Laktam-inneholdende forbindelser og derivater derav som faktor XA-inhibitorer
ATE323093T1 (de) Neue xanthinderivate, deren herstellung und deren verwendung als arzneimittel
NO20066055L (no) Pyridinderivater
NO20075809L (no) DNA-PK inhibitorer
DK0956282T3 (da) Sulfinsyrederivater, fremgangsmåde til deres fremstilling og anvendelse
TW200504067A (en) New substituted imidazo-pyridinones and imidazo-pyridazinones, the preparation thereof and their use as pharmaceutical compositions
WO2004043337A3 (en) Indole, azaindole and related heterocyclic 4-alkenyl piperidine amides
NO20062092L (no) Nye fremgangsmater for fremstilling av N-desmetylzopiklon og optisk rent (+)-N-desmetylzopiklon og optisk rent (-)-N-desmetylzopiklon
BR0207270A (pt) Compostos de triazol como inibidores de mmp
PT946546E (pt) Derivados da piridin-2-il-metilamina processo de preparacao e aplicacao daqueles como medicamentos
EP1794120A4 (en) peptidase
NO20055068L (no) Kjemiske forbindelser
ATE347555T1 (de) 6-aminomorphinanderivate, herstellungsverfahren dafür und deren verwendung
DE60221508D1 (de) Aminosäurederivate als hiv-protease-inhibitoren
ATE318813T1 (de) Neue kristalline formen von meloxicam, deren herstellung und verfahren zu deren umwandlung ineinander
DE69821347D1 (de) (2-(2-thienyl)-ethylamino)-(2-halophenyl)-acetonitrile als zwischenprodukte und verfahren zu ihrer herstellung
SE0300850D0 (sv) Chemical compounds
SE0200843D0 (sv) Chemical compounds
DE60104687D1 (de) Mikrofiltration unter verwendung von aktivkohle
NO20001749L (no) Fremstilling av asymmetriske sykliske ureaforbindelser via et monoacylert diaminintermediat

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application